141 related articles for article (PubMed ID: 21745273)
1. Changes in body composition after transjugular intrahepatic portosystemic stent in cirrhosis: a critical review of literature.
Dasarathy J; Alkhouri N; Dasarathy S
Liver Int; 2011 Oct; 31(9):1250-8. PubMed ID: 21745273
[TBL] [Abstract][Full Text] [Related]
2. TIPS implantation raises leptin levels in patients with liver cirrhosis.
Nolte W; Wirtz M; Rossbach C; Leonhardt U; Buchwald AB; Scholz KH; Ramadori G
Exp Clin Endocrinol Diabetes; 2003 Oct; 111(7):435-42. PubMed ID: 14614651
[TBL] [Abstract][Full Text] [Related]
3. Effect of transjugular intrahepatic portosystemic shunt on glycometabolism in cirrhosis patients.
Su AP; Cao SS; Le Tian B; Da Zhang Z; Hu WM; Zhang Y; Wang ZL; Babu SR; Hu T
Clin Res Hepatol Gastroenterol; 2012 Feb; 36(1):53-9. PubMed ID: 22099870
[TBL] [Abstract][Full Text] [Related]
4. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
5. Changes in adipokines after transjugular intrahepatic porto-systemic shunt indicate an anabolic shift in metabolism.
Thomsen KL; Sandahl TD; Holland-Fischer P; Jessen N; Frystyk J; Flyvbjerg A; Grønbæk H; Vilstrup H
Clin Nutr; 2012 Dec; 31(6):940-5. PubMed ID: 22541535
[TBL] [Abstract][Full Text] [Related]
6. Effects of ascites resolution after successful TIPS on nutrition in cirrhotic patients with refractory ascites.
Allard JP; Chau J; Sandokji K; Blendis LM; Wong F
Am J Gastroenterol; 2001 Aug; 96(8):2442-7. PubMed ID: 11513188
[TBL] [Abstract][Full Text] [Related]
7. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
[TBL] [Abstract][Full Text] [Related]
8. Body composition changes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis.
Montomoli J; Holland-Fischer P; Bianchi G; Grønbaek H; Vilstrup H; Marchesini G; Zoli M
World J Gastroenterol; 2010 Jan; 16(3):348-53. PubMed ID: 20082481
[TBL] [Abstract][Full Text] [Related]
9. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
10. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone versus TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study.
Xiao T; Chen L; Chen W; Xu B; Long Q; Li R; Li L; Peng Z; Fang D; Wang R
J Clin Gastroenterol; 2011 Aug; 45(7):643-50. PubMed ID: 21301360
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Transjugular Intrahepatic Portosystemic Shunt on Nutrition in Liver Cirrhosis Patients: A Systematic Review.
Gazda J; Di Cola S; Lapenna L; Khan S; Merli M
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049459
[TBL] [Abstract][Full Text] [Related]
12. Urinary aquaporin-2 excretion before and after transjugular intrahepatic portosystemic shunt insertion for refractory ascites.
Geilswijk M; Thomsen KL; Pedersen EB; Vilstrup H; Grønbæk H
Scand J Gastroenterol; 2015 Apr; 50(4):454-61. PubMed ID: 25637473
[TBL] [Abstract][Full Text] [Related]
13. Transjugular intrahepatic portosystemic shunt prior to cardiac surgery with cardiopulmonary bypass in patients with cirrhosis and portal hypertension.
Semiz-Oysu A; Moustafa T; Cho KJ
Heart Lung Circ; 2007 Dec; 16(6):465-8. PubMed ID: 17446133
[TBL] [Abstract][Full Text] [Related]
14. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
Saad WE; Darwish WM; Davies MG; Waldman DL
J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
[TBL] [Abstract][Full Text] [Related]
15. Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent.
Tsien C; Shah SN; McCullough AJ; Dasarathy S
Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):85-93. PubMed ID: 23011041
[TBL] [Abstract][Full Text] [Related]
16. Transjugular intrahepatic portosystemic shunt (TIPS) in patients with refractory ascites: effect on body weight and Child-Pugh score.
Trotter JF; Suhocki PV; Rockey DC
Am J Gastroenterol; 1998 Oct; 93(10):1891-4. PubMed ID: 9772050
[TBL] [Abstract][Full Text] [Related]
17. Insulin sensitivity and body composition in cirrhosis: changes after TIPS.
Holland-Fischer P; Nielsen MF; Vilstrup H; Tønner-Nielsen D; Mengel A; Schmitz O; Grønbaek H
Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G486-93. PubMed ID: 20489042
[TBL] [Abstract][Full Text] [Related]
18. Impact of nutritional status on the outcome of transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a systematic review.
Giri S; Anirvan P; Chaudhary M; Tripathy T; Patel RK; Rath MM; Panigrahi MK
Br J Radiol; 2024 Feb; 97(1154):331-340. PubMed ID: 38276881
[TBL] [Abstract][Full Text] [Related]
19. Transjugular intrahepatic portosystemic shunt in five children with cystic fibrosis: long-term results.
Pozler O; Krajina A; Vanicek H; Hulek P; Zizka J; Michl A; Elias P
Hepatogastroenterology; 2003; 50(52):1111-4. PubMed ID: 12845992
[TBL] [Abstract][Full Text] [Related]
20. Transjugular intrahepatic portosystemic stent-shunt after orthotopic liver transplantation in a patient with early recurrence of portal hypertension of unknown origin.
Nolte W; Canelo R; Figulla HR; Kersten J; Sattler B; Münke H; Hartmann H; Ringe B; Ramadori G
Z Gastroenterol; 1998 Feb; 36(2):159-64. PubMed ID: 9544499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
